Pine Labs IPO GMP Today At 3% Ahead of Listing: Issue Subscribed 2.48× — Check Latest GMP & Listing Expectations!
Pine Labs IPO GMP Today: As India’s fintech sector continues its strong growth trajectory, Pine Labs Ltd.’s IPO has caught the eye of both institutional and retail investors. Pine Labs IPO GMP today stands at ₹6.5 around 3% from the upper price band.
From its price band and lot size to the latest Grey Market Premium (GMP) movements, the Pine Labs IPO is shaping up to be one of the most talked-about listings of 2025.
What Is the Pine Labs IPO GMP Today & its Trend?
The Pine Labs IPO GMP today reflects early investor sentiment before the official listing. While GMPs are unofficial indicators, they often highlight market buzz and expected listing gains.
Pine Labs IPO GMP Live Rates
| Date | IPO GMP (₹) | GMP Trend | Approx. Gain |
|---|---|---|---|
| 6 Nov 2025 | ₹17 | Down | 7.69% |
| 7 Nov 2025 | ₹12 | Down | 5.42% |
| 8 Nov 2025 | ₹5.5 | Down | 2.49% |
| 10 Nov 2025 | ₹4 | Down | 2.00% |
| 12 Nov 2025 | ₹3 | Down | 1.85% |
| 13 Nov 2025 | ₹6.5 | Up | 2.94% |
Although the Pine Labs IPO GMP today has slightly cooled, it still indicates healthy interest from the grey market and retail investors.
A decline over subsequent days indicates that grey market traders are factoring in valuation concerns and broader market volatility.
What Are the Key Details of the Pine Labs IPO?
Pine Labs’ IPO is one of the biggest fintech offerings in recent years. Below are the complete issue details, including price band, size, and important timelines.
Pine Labs IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | November 7, 2025 |
| IPO Close Date | November 11, 2025 |
| Face Value | ₹1 per equity share |
| Price Band | ₹210 to ₹221 per share |
| Issue Size | ₹3,899.91 crore (approx.) |
| Fresh Issue | ₹2,080 crore |
| Offer for Sale (OFS) | 8,23,48,779 equity shares |
| Issue Type | Book Built Issue |
| Listing Exchanges | BSE and NSE |
When Is Allotment & Listing — What Listing Gains Are Expected?
- Allotment date: Reported to be finalised on 11–12 November (registrar timelines vary by outlet).
- Refund/credit to demat: Likely a day after allotment
- Listing date: Market updates point to 14 November listing on BSE/NSE.
Listing gains expectation: Given the small GMP (2–3%) and mixed demand trajectory, most brokers and live trackers estimated a modest listing upside (single-digit to low-teens percent in optimistic broker notes). Some sell-side research (select brokers) has tagged higher upside scenarios based on recovery in profitability, but the market’s immediate pricing is cautious.
What do experts say about Pine Labs IPO — buy, skip, or hold?
Market voices are split:
- Institutional confidence: QIB demand was strong (near 4×), signalling institutional belief in Pine Labs’ business recovery and TPV (total payment value) growth.
- Caution on valuation & profitability: Reuters and other analysts highlight past losses and valuation concerns; several research houses flagged this as a buy for long-term investors but advised caution for short-term listing chases.
- Broker views: A mix of “Subscribe for long term” and “Neutral for listing trade” — depends on risk appetite and holding horizon.
What should investors do post-listing?
- If you want a quick list gain: GMP/current sentiment suggests modest expectation; avoid assuming large one-day pops. If GMP is low (2–3% or flat), listing gains may be limited.
- If you are a long-term investor: Evaluate fundamentals — revenue growth, margins turnaround, market share in merchant commerce and BNPL/merchant finance. Experts who like the business recommend holding for structural growth rather than short flips.
- Risk management: Use stop-losses if trading post-listing; don’t over-leverage on IPO allocations. Consider the allotment outcome (small retail allotments are common when QIBs dominate).
- Check allotment/credit timelines: Confirm allotment on the registrar / exchange and verify refund/credit dates before making trade decisions.
Bottom line
Pine Labs’ IPO closed well above the weak early interest — finishing at ~2.46–2.48× with QIBs driving demand. Pine Labs IPO GMP today indicates around 2–3% points to muted listing euphoria; the smart play depends on your horizon.
Short-term listing traders should be cautious given modest grey-market signals; long-term investors who buy the business case and margin recovery may find value — but only after confirming allotment and sizing positions sensibly.
Pine Labs IPO GMP Today FAQs (Frequently Asksed Questions)
Q1. What is the Pine Labs IPO date?
• The Pine Labs IPO opens on November 7, 2025, and closes on November 11, 2025.
Q2. What is the price band of the Pine Labs IPO?
• The price band is ₹210 to ₹221 per share.
Q3. What is the Pine Labs IPO lot size?
• The minimum lot size is 67 shares per application.
Q4. How much is Pine Labs IPO expected to raise?
• The company aims to raise around ₹3,900 crore through this IPO.
Q5. What is the Pine Labs IPO GMP today?
• The Pine Labs IPO GMP today is around ₹6.5, indicating slowing investor demand.
Q6. What is the estimated listing gain based on GMP?
• The expected listing gain is approximately 2%-3% from the upper price band.
Q7. When will the Pine Labs IPO allotment be finalized?
• The allotment is likely to be finalized on November 12, 2025.
Q8. When will the Pine Labs shares list on stock exchanges?
• The shares are expected to list on November 14, 2025, on BSE and NSE.
Q9. Who are the lead managers of the Pine Labs IPO?
• Morgan Stanley, Goldman Sachs, and ICICI Securities are the book-running lead managers.
Q10. How can investors check Pine Labs IPO allotment status?
• Investors can check via the official registrar’s website, Link Intime India Pvt Ltd, using PAN or application number.
Click Here to know more market & IPO related news and updates.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
